How the conversation moved Democrat Republican · one dot = one action
Emerging events 1 thread · 6 of 51 actions
2 members
Oct 2 Shaheen highlighted editorial support for INSULIN Act capping monthly insulin costs at $35.Oct 8 Shaheen released video highlighting INSULIN Act and state gaps in insulin cost caps.Oct 21 Schrier joined healthcare leaders to discuss her bill capping insulin costs at $35 monthly for all Americans.Nov 17 Shaheen highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.Nov 17 Shaheen pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.
What each party did · Democrats 34 · Republicans 17
4 Sent letters 2 3 Hearings 3 3 Statements 0 2 Criticized 0 3 Praised 2 1 Visits and events 1 16 Filed or pushed bills 8 2 Other 1
By state Actions by members from each state, split by party. A joint release counts once for each member on it.
+19 more with fewer actions
Recognitions and tributes not counted.
Every action 51 actions · 53 releases
All types 51 Sent letters 6 Hearings 6 Statements 3 Criticized 2 Praised 5 Visits and events 2 Filed or pushed bills 24 Other 3
All D R
Nov 20, 2026
Bill
D Bennet CO
Introduced bill to lower prescription drug costs by expanding access to biosimilars.
Release ↗
Nov 19, 2026
Letter
D Shaheen NH $200M
Led 243 lawmakers urging reauthorization of Special Diabetes Program before December 31 expiration.
Release ↗
Nov 17, 2026
Statement
Statement
Bill
D Welch VT
Pushed bipartisan bill to lower prescription drug costs by streamlining patent litigation for generic drugs.
Release ↗
Criticism
D Murray WA
Opposed FDA nominee Heidi Overton's confirmation, citing anti-abortion extremism and medication abortion stance.
Release ↗
Hearing
R Grassley IA
Held hearing examining competition and transparency to lower prescription drug costs.
Release ↗
Hearing
D Durbin IL
Called for passage of bipartisan Drug-price Transparency for Consumers Act during Senate Judiciary Committee hearing.
Release ↗
Hearing
D Durbin IL
Questioned witnesses about Medicare's authority to negotiate prescription drug costs during Senate Judiciary Committee hearing.
Release ↗
Hearing
Hearing
R Britt AL
Questioned witnesses at Senate Judiciary Committee hearing on lowering prescription drug costs.
Release ↗
Nov 11, 2026
Letter
Bill
R Bergman MI
Introduced bipartisan bill to preserve prescription drug discounts for safety-net providers.
Release ↗
Nov 3, 2026
Oct 29, 2026
Bill
D Matsui CA
Introduced bipartisan bill to protect patient access to affordable medications through 340B program.
Release ↗
Oct 27, 2026
Oct 22, 2026
Letter
R Grassley IA
Urged FTC to complete pharmacy benefit manager investigation and release final recommendations.
Release ↗
Oct 21, 2026
Oct 20, 2026
Statement
D Larsen WA
Praised Trump administration's delay of CBP rule that would restrict affordable prescription medication access.
Release ↗
Oct 16, 2026
Praise
D Shaheen NH
Highlighted bipartisan support for INSULIN Act to cap monthly insulin costs at $35.
Release ↗
Oct 14, 2026
Oct 9, 2026
Bill
R Bresnahan PA
Introduced bipartisan bill to delay 340B drug rebate model implementation to protect patient access.
Release ↗
Statement
D Courtney CT
Wrote op-ed calling for Congress to address rising health care premiums driven by drug costs.
Release ↗
Oct 8, 2026
Oct 5, 2026
Criticism
D Doggett TX
Criticized insurers' preferential treatment of their own pharmacies in drug pricing.
Release ↗
Oct 2, 2026
Letter
D Schakowsky IL
Led letter from 71 members urging agencies to allow continued prescription drug imports from Canada.
Release ↗
Praise
Bill
Oct 1, 2026
Letter
D Pocan WI
Led letter to HHS and DHS urging continued allowance of prescription drug imports from Canada.
Release ↗
Bill
D Bonamici OR
Introduced bipartisan bill to establish 10,000 secure opioid disposal receptacles nationwide.
Release ↗
Sep 29, 2026
Bill
D Warner VA
Introduced bipartisan bill to improve pharmacy reimbursement data and reduce patient out-of-pocket costs.
Release ↗
Sep 28, 2026
Sep 24, 2026
Hearing
D Murray WA
Questioned FDA nominee on mifepristone safety, medication abortion, and food safety failures.
Release ↗
Bill
Sep 23, 2026
Statement
Bill
R Marshall KS
Sought unanimous consent for bill requiring upfront healthcare price transparency for patients.
Release ↗
Sep 18, 2026
Praise
R Meuser PA
Commended Trump administration for extending Most Favored Nation drug pricing to all state Medicaid programs.
Release ↗
Sep 17, 2026
Sep 16, 2026
Sep 15, 2026
Bill
D McBath GA
Introduced bipartisan bill to increase transparency in prescription drug pricing.
Release ↗
Sep 14, 2026
Bill
D Sewell AL
Introduced bill to extend Medicare Part D premium stabilization through 2029.
Release ↗
Sep 11, 2026
Letter
R Tenney NY
Sent letter to HHS and CMS recommending Medicare incentives for American-made essential medicines.
Release ↗
Sep 3, 2026
Bill
Bill
Praise
D Shaheen NH
Praised House introduction of bipartisan bill capping monthly insulin out-of-pocket costs at $35.
Release ↗
Bill
Bill
Sep 2, 2026
Bill
D Scholten MI
Introduced two bills to lower prescription drug prices and protect hospital drug discounts.
Release ↗
Bill
D Shaheen NH
Highlighted bipartisan bill capping monthly insulin costs at $35 for insured and uninsured Americans.
Release ↗
Sep 1, 2026
Visit
R Hyde-Smith MS
Met with pharmacists to discuss pharmacy benefit manager reform and prescription drug costs.
Release ↗
Aug 31, 2026
Bill
R Bilirakis FL
Introduced bill to redirect Medicare Part D premium relief to seniors instead of insurance companies.
Release ↗
Summaries, action types, amounts and positions are read from each press release by AI and can be wrong. Joint releases (same day, same action, matching title or amount) count once. How it works